← Back to Research Radar
Academic Publication Academic Publication

Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy

64
Citations
October 1, 2024
Published Date

Research Abstract & Technology Focus

AbstractFerroptosis in neurons is considered one of the key factors that induces Parkinson's disease (PD), which is caused by excessive iron accumulation in the intracellular labile iron pool (LIP). The iron ions released from the LIP lead to the aberrant generation of reactive oxygen species (ROS) to trigger ferroptosis and exacerbate PD progression. Herein, a pioneering design of multifunctional nanoregulator deferoxamine (DFO)‐integrated nanosheets (BDPR NSs) is presented that target the LIP to restrict ferroptosis and protect against PD. The BDPR NSs are constructed by incorporating a brain‐targeting peptide and DFO into polydopamine‐modified black phosphorus nanosheets. These BDPR NSs can sequester free iron ions, thereby ameliorating LIP overload and regulating iron metabolism. Furthermore, the BDPR NSs can decrease lipid peroxidation generation by mitigating ROS accumulation. More importantly, BDPR NSs can specifically accumulate in the mitochondria to suppress ROS generation and decrease mitochondrial iron accumulation. In vivo experiments demonstrated that the BDPR NSs highly efficiently mitigated dopaminergic neuronloss and its associated behavioral disorders by modulating the LIP and inhibiting ferroptosis. Thus, the BDPR‐based nanovectors holds promise as a potential avenue for advancing PD therapy.
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
100%
🔥

Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy

AbstractFerroptosis in neurons is considered one of the key factors that induces Parkinson's disease (PD), which is caused by excessive iron accumulation in the intracellular labile iron pool (LIP)...

crossref.org › academic paper
0%

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects

AbstractIron, an essential mineral in the body, is involved in numerous physiological processes, making the maintenance of iron homeostasis crucial for overall health. Both iron overload and defici...

crossref.org › academic paper
0%

PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma

Abstract Background Sorafenib is a standard first-line treatment for advanced hepatocellular carcinoma (HCC), yet its effectiveness is often constrained. Emerging st...

crossref.org › academic paper
0%

Enhancing Drug Solubility, Bioavailability, and Targeted Therapeutic Applications through Magnetic Nanoparticles

Biological variability poses significant challenges in the development of effective therapeutics, particularly when it comes to drug solubility and bioavailability. Poor solubility across varying p...

roipad.com › trend story
0%

Enhanced Peroxidase-like Activity of Palladium-Iron Bimetallic Nanoparticles Supported on N-doped Mesoporous Carbon for Colorimetric Detection of Ascorbic Acid and Dopamine

Nanoscale, 2026, Accepted ManuscriptDOI: 10.1039/D6NR00031B, PaperZahra Bahreini, Siyavash Kazemi Movahed, Keun Hwa Chae, Cheol-Hwee ShimNanozymes, despite their promising stability and cost-effect...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy'?

This literature focuses on: AbstractFerroptosis in neurons is considered one of the key factors that induces Parkinson's disease (PD), which is caused by excessive iron accumulation in the intracellular labile iron pool (LIP). The iron ions released from the LIP lead to the ...

Are there open-source GitHub repositories related to Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy?

Yes, open-source projects like jackwener/xiaohongshu-cli (A CLI for Xiaohongshu (小红书) — search, read, interact via reverse-engineered API) are actively building upon these concepts.

Which startups are commercializing the technology behind Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy?

Products like Open Claude in Chrome are bringing this to market. Their focus is: Claude in Chrome, reverse-engineered, Jailbroken.

What other academic literature is closely related to 'Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy'?

Yes, highly correlated activity was mapped. An entry titled 'Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy' discusses this: AbstractFerroptosis in neurons is considered one of the key factors that induces Parkinson's disease (PD), which is caused by excessive iron accumu...

Are there commercial applications of 'Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy' in market news publications?

Yes, highly correlated activity was mapped. An entry titled 'Enhanced Peroxidase-like Activity of Palladium-Iron Bimetallic Nanoparticles Supported on N-doped Mesoporous Carbon for Colorimetric Detection of Ascorbic Acid and Dopamine' discusses this: Nanoscale, 2026, Accepted ManuscriptDOI: 10.1039/D6NR00031B, PaperZahra Bahreini, Siyavash Kazemi Movahed, Keun Hwa Chae, Cheol-Hwee ShimNanozymes,...

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative